Journal: Anticancer research

Article Title: Prognostic Impact of Intraoperative Blood Loss in Liver Transplant Patients with Advanced Hepatocellular Carcinoma.

PMID/MRN: 27798899

Publication Date: 2016-Oct-01

Abstract:

The aim of this retrospective study was to analyze the impact of intraoperative blood loss (IOBL) on outcome in liver transplant (LT) patients with advanced hepatocellular carcinoma (HCC). A total of 108 LT patients with HCC were retrospectively analyzed. They were all clinically staged according to the Milan criteria and to 18 F-fluoro-D-glucose ( 18 F-FDG) uptake on positron-emission tomography (PET). Recurrence-free survival rates at 3 and 5 years post-LT were 91.9% and 91.9% among patients with low (²1,500 ml) IOBL, and 43.9% and 37.1% in those with high (>1,500 ml) IOBL (log-rank p<0.001). Multivariate analysis demonstrated low IOBL to be an independent predictor of better recurrence-free survival in patients with HCC exceeding the Milan criteria (hazard ratio=3.66; p=0.029) and in those with PET-positive tumors (hazard ratio=4.13; p=0.007). Intraoperative bleeding is associated with increased likelihood of tumor recurrence following LT for HCC. Limiting IOBL should be considered for improving post-LT outcome, particularly in patients with HCC beyond standard criteria. Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.